| 2025-02-11 | +1.64 % |
|
| 2025-02-07 | +1.26 % |
|
| 2025-02-06 | -1.09 % |
- Colgate-Palmolive (CL) stock declined by 1.09% after JPMorgan Chase & Co. reduced its price target for the stock from $103.00 to $97.00, contributing to a trend of lowered price targets from various analysts.
- Colgate-Palmolive's stock (NYSE:CL) is down 1.09% amid recent analyst downgrades of its price targets, with JPMorgan, Barclays, Stifel Nicolaus, TD Cowen, and UBS Group all revising their price objectives lower due to various market conditions and concerns regarding the company's performance.
- Colgate-Palmolive (CL) stock decreased by 1.09% following multiple downgrades and price target reductions from several brokerages, including a cut from Stifel Nicolaus from $95.00 to $93.00, indicating a general sentiment of caution among analysts toward the stock.
- Colgate-Palmolive (CL) stock declined by -1.09% after UBS cut its price target from $104.00 to $100.00, which is part of a broader trend where several analysts have lowered their price targets on the stock, indicating reduced confidence in its performance.
|
| 2025-02-05 | +0.14 % |
|
| 2025-02-04 | -0.61 % |
|
| 2025-01-31 | -4.61 % |
|
| 2025-01-29 | -0.32 % |
|
| 2025-01-23 | +0.41 % |
|
| 2025-01-22 | -0.77 % |
|
| 2025-01-16 | +0.8 % |
|
| 2025-01-15 | +0.22 % |
- Colgate-Palmolive's stock, which was up 0.22%, benefited from increased institutional investment, as several hedge funds expanded their holdings during the last quarter, indicating positive sentiment towards the company's future prospects.
- Colgate-Palmolive (CL) stock has seen a slight increase of 0.22% as it maintains a "Moderate Buy" consensus rating among analysts, despite some recent downgrades from various firms, likely driven by a combination of adjusted price targets, ongoing institutional investment, and a recently declared quarterly dividend.
The stock's rise can be attributed to positive analyst sentiment regarding its potential for growth and profitability, despite the mixed ratings from some analysts.
- Colgate-Palmolive (CL) stock experienced a slight increase of 0.22% due to its stronger revenue growth, better profitability, and lower financial risk compared to its peer Kimberly-Clark (KMB), making it a more attractive investment choice.
|
| 2025-01-14 | +0.65 % |
|
| 2025-01-13 | +0.86 % |
|
| 2025-01-10 | -1.26 % |
|
| 2025-01-07 | -0.17 % |
|
| 2025-01-06 | -2.9 % |
|
| 2025-01-03 | -0.44 % |
|
| 2025-01-02 | -0.4 % |
|
| 2024-12-18 | -0.79 % |
|
| 2024-12-16 | -0.56 % |
|
| 2024-12-05 | +0.31 % |
|
| 2024-11-29 | -0.13 % |
|
| 2024-11-27 | +0.19 % |
|
| 2024-11-22 | +0.71 % |
|
| 2024-11-18 | +1.13 % |
|
| 2024-11-12 | -0.5 % |
|
| 2024-11-06 | -4.29 % |
|
| 2024-11-05 | +0.69 % |
|
| 2024-11-01 | -0.41 % |
- Colgate-Palmolive's (CL) stock decreased by 0.41% due to increased competition from Amazon and other retailers, who are pushing down average selling prices by offering lower-priced essentials like toothpaste, which pressures Colgate's profitability.
- Colgate-Palmolive (CL) stock declined by 0.41% primarily due to increased competition in the essential goods market from lower-priced rivals like Amazon, Shein, and Temu, which is impacting selling prices and market dynamics.
- Colgate-Palmolive (NYSE:CL) stock declined by 0.41% following a series of downgrades and lowered price targets from various analysts, including TD Cowen's reduction from $115.00 to $110.00 and Deutsche Bank's downgrade from "buy" to "hold."
- Colgate-Palmolive (CL) stock fell by 0.41% following reports of institutional investors, including Pallas Capital Advisors LLC, significantly reducing their stakes in the company, alongside downgrades and target price reductions by several equity analysts.
- Colgate-Palmolive (CL) stock dropped by 0.41%, likely due to increased insider selling activity and mixed signals from institutional investment changes, as such sales can negatively impact investor confidence.
|
| 2024-10-30 | -0.06 % |
|
| 2024-10-29 | -1.07 % |
|
| 2024-10-28 | +0.14 % |
|
| 2024-10-25 | -4.14 % |
|
| 2024-10-24 | +0.77 % |
|
| 2024-10-23 | -0.69 % |
|
| 2024-10-22 | +0.31 % |
|
| 2024-10-21 | -1.09 % |
|
| 2024-10-18 | -0.07 % |
- Colgate-Palmolive (CL) stock experienced a decline of 0.07% following a report that Teamwork Financial Advisors LLC acquired a new stake in the company during the third quarter. The exact reasons for the stock's decrease were not specified in the article.
- Colgate-Palmolive (CL) stock experienced a minor decline of 0.07% following reports of insider sales of shares and mixed market sentiment, despite a significant increase in holdings by hedge funds during the third quarter.
- Colgate-Palmolive (CL) stock experienced a slight decline of 0.07% amidst a market filled with potential earnings reports, with analysts, including Jim Cramer, suggesting that while Wall Street may have a positive outlook on the stock, it could be overly enthusiastic, thus contributing to the slight downturn.
- Colgate-Palmolive's stock (NYSE: CL) declined by 0.07% recently, influenced by institutional investors, like CX Institutional, reducing their holdings amidst fluctuating analyst ratings and insider sales.
- Colgate-Palmolive (CL) stock decreased by 0.07% possibly due to mixed analyst ratings and insider stock sales, which may suggest concerns about future performance ahead of its upcoming earnings announcement.
|
| 2024-10-16 | -0.35 % |
|
| 2024-10-15 | +0.81 % |
|
| 2024-10-14 | +0.63 % |
|
| 2024-10-11 | +0.87 % |
|
| 2024-10-10 | -1.74 % |
|
| 2024-10-04 | -0.93 % |
|
| 2024-10-03 | -2.05 % |
|
| 2024-10-02 | -0.26 % |
|
| 2024-10-01 | -1.43 % |
|
| 2024-09-30 | +0.14 % |
|
| 2024-09-27 | +0.58 % |
|
| 2024-09-26 | -0.67 % |
|
| 2024-09-25 | -0.04 % |
|
| 2024-09-24 | +0.46 % |
|
| 2024-09-23 | +0.24 % |
|
| 2024-09-20 | +1.03 % |
|
| 2024-09-17 | -0.83 % |
|
| 2024-09-16 | -0.28 % |
|
| 2024-09-13 | -0.57 % |
|
| 2024-09-10 | -0.25 % |
|
| 2024-09-06 | -0.62 % |
|
| 2024-09-03 | +1.2 % |
|
| 2024-08-30 | +0.65 % |
|
